Editorial Perspective
We Asked the Experts: Toward Personalized Immunosuppression for Liver Transplant Recipients
Joey Lew,
Corresponding Author
Joey Lew
School of Medicine, University of California, 505 Parnassus Ave, 94143 San Francisco, CA, USA
[email protected]Search for more papers by this author Emily R. Perito,
Emily R. Perito
School of Medicine, University of California, 505 Parnassus Ave, 94143 San Francisco, CA, USA
Search for more papers by this author Sandy Feng,
Sandy Feng
School of Medicine, University of California, 505 Parnassus Ave, 94143 San Francisco, CA, USA
Search for more papers by this author
Joey Lew,
Corresponding Author
Joey Lew
School of Medicine, University of California, 505 Parnassus Ave, 94143 San Francisco, CA, USA
[email protected]Search for more papers by this author Emily R. Perito,
Emily R. Perito
School of Medicine, University of California, 505 Parnassus Ave, 94143 San Francisco, CA, USA
Search for more papers by this author Sandy Feng,
Sandy Feng
School of Medicine, University of California, 505 Parnassus Ave, 94143 San Francisco, CA, USA
Search for more papers by this author
First published: 17 January 2022
No abstract is available for this article.
References
- 1Vionnet J, Miquel R, Abraldes JG et al. Non-invasive alloimmune risk stratification of long-term liver transplant recipients. J Hepatol (2021) 75(6): 1409–141910.1016/j.jhep.2021.08.007
- 2Saunders EA, Engel B, Höfer A et al. Outcome and safety of a surveillance biopsy guided personalized immunosuppression program after liver transplantation. Am J Transplant (2021) 10.1111/ajt.1681734455702
- 3Levitsky J, Kandpal M, Guo K et al. Donor-derived cell-free DNA levels predict graft injury in liver transplant recipients. Am J Transplant (2021) 10.1111/ajt.1683534951518
- 4Feng S, Bucuvalas JC, Demetris AJ et al. Evidence of chronic allograft injury in liver biopsies from long-term pediatric recipients of liver transplants. Gastroenterology (2018) 155: 1838–185110.1053/j.gastro.2018.08.023
- 5Londoño MC, Souza LN, Lozano JJ et al. Molecular profiling of subclinical inflammatory lesions in long-term surviving adult liver transplant recipients. J Hepatol (2018) 69: 626–63410.1016/j.jhep.2018.04.012
